Suppr超能文献

美国各地基本生命支持中可获取注射用肾上腺素的情况。

Basic Life Support Access to Injectable Epinephrine across the United States.

作者信息

Brasted Ian D, Dailey Michael W

出版信息

Prehosp Emerg Care. 2017 Jul-Aug;21(4):442-447. doi: 10.1080/10903127.2017.1294224. Epub 2017 Mar 24.

Abstract

BACKGROUND

Aggressive epinephrine administration has growing support in the treatment of anaphylaxis, a life-threatening allergic reaction. Emergency Medical Services (EMS) providers are frequently in a position to provide the first care to someone experiencing an anaphylactic reaction. Intramuscular injection of epinephrine is the definitive pharmacologic treatment for many associated symptoms. While easy to use, epinephrine autoinjectors (EAI) are prohibitively expensive, having increased in price ten-fold in ten years. Some states and EMS departments have begun expanding the scope of practice to allow Basic Life Support (BLS) providers, previously restricted to noninvasive therapies, to administer epinephrine by syringe.

OBJECTIVES

To compile a current and comprehensive list of how epinephrine is carried and used by EMS across the USA.

METHODS

An online survey focusing on anaphylaxis protocols and epinephrine administration was sent to state EMS medical directors and officials in all 50 states. Follow-up telephone calls were made to ensure compliance. Data were analyzed with descriptive statistics.

RESULTS

Forty-nine of the 50 states in the USA provided a survey response. Texas responded but declined to participate in the survey because of practice variability across the state. In the other states, the form of epinephrine allowed or required on BLS ambulances was consistent with the scope of practice of their Basic Emergency Medical Technician (EMT). Thirteen states had training programs to allow BLS providers to inject epinephrine; 7 were considering it; 29 were not. Twenty-seven states specified EAI as the only form of epinephrine required or allowed on their BLS ambulances. No states reported allowing any level of EMS provider below EMT to use alternatives to EAI.

CONCLUSION

This study confirms that many states have expanded the training of BLS providers to include the use of syringe injectable epinephrine. Even so, the majority of states relied on EAI in BLS ambulances.

摘要

背景

在治疗过敏反应(一种危及生命的过敏反应)方面,积极使用肾上腺素的做法得到越来越多的支持。紧急医疗服务(EMS)提供者常常是为过敏反应患者提供首诊治疗的人员。肌肉注射肾上腺素是治疗许多相关症状的决定性药物治疗方法。虽然肾上腺素自动注射器(EAI)使用方便,但价格贵得令人望而却步,十年内价格上涨了十倍。一些州和EMS部门已开始扩大执业范围,允许以前仅限于非侵入性治疗的基础生命支持(BLS)提供者使用注射器注射肾上腺素。

目的

汇编一份关于美国各地EMS携带和使用肾上腺素情况的最新综合清单。

方法

向美国所有50个州的州EMS医疗主任和官员发送了一份关于过敏反应方案和肾上腺素给药的在线调查问卷。进行了后续电话随访以确保合规。使用描述性统计方法对数据进行分析。

结果

美国50个州中有49个州回复了调查问卷。得克萨斯州回复了,但因全州执业情况存在差异而拒绝参与调查。在其他州,BLS救护车允许或要求配备的肾上腺素形式与其基础急救医疗技术员(EMT)的执业范围一致。13个州有培训项目允许BLS提供者注射肾上腺素;7个州正在考虑;29个州没有。27个州规定EAI是其BLS救护车上所需或允许的唯一肾上腺素形式。没有州报告允许EMT以下任何级别的EMS提供者使用EAI的替代产品。

结论

本研究证实,许多州已扩大了对BLS提供者的培训,使其包括使用注射器注射肾上腺素。即便如此,大多数州的BLS救护车仍依赖EAI。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验